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Abstract
Planarian flatworms are able to both regenerate their whole bodies and continuously adapt their size to nutrient status.
Tight control of stem cell proliferation and differentiation during these processes is the key feature of planarian biology.
Here we show that the planarian homolog of the phosphoinositide 3-kinase-related kinase (PIKK) family member SMG-1 and
mTOR complex 1 components are required for this tight control. Loss of smg-1 results in a hyper-responsiveness to injury
and growth and the formation of regenerative blastemas that remain undifferentiated and that lead to lethal ectopic
outgrowths. Invasive stem cell hyper-proliferation, hyperplasia, hypertrophy, and differentiation defects are hallmarks of this
uncontrolled growth. These data imply a previously unappreciated and novel physiological function for this PIKK family
member. In contrast we found that planarian members of the mTOR complex 1, tor and raptor, are required for the initial
response to injury and blastema formation. Double smg-1 RNAi experiments with tor or raptor show that abnormal growth
requires mTOR signalling. We also found that the macrolide rapamycin, a natural compound inhibitor of mTORC1, is able to
increase the survival rate of smg-1 RNAi animals by decreasing cell proliferation. Our findings support a model where Smg-1
acts as a novel regulator of both the response to injury and growth control mechanisms. Our data suggest the possibility
that this may be by suppressing mTOR signalling. Characterisation of both the planarian mTORC1 signalling components
and another PIKK family member as key regulators of regeneration and growth will influence future work on regeneration,
growth control, and the development of anti-cancer therapies that target mTOR signalling.
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Introduction
Planarian flatworms have a remarkable plasticity that has driven
the curiosity of scientists for more than a century [1,2]. These
abilities rely on adult stem cells called neoblasts, which are able to
give rise to all types of differentiated cells in the planarian body
[3,4]. Planarians have a growing importance as a model system as
one of the more extreme examples of regeneration [5–7]; even tiny
fragments of their body are able to regenerate a completely
proportioned organism in about 2 weeks. After amputation
neoblasts undergo a broadly distributed increased mitotic response
to injury in the first 4–10 h and a second more spatially restricted
mitotic response at 48–72 h, specifically in response to missing
tissue [8,9]. Neoblast progeny migrate and form an unpigmented
tissue called the blastema. The blastema becomes progressively
pigmented and neoblasts terminally differentiate to form missing
structures. In addition to the formation of new structures at the
blastema, homeostatic changes in the old tissue are also necessary
for the planarian to remodel its body. Similarly, uninjured
planarians constantly replace aged differentiated cells from the
mitotic progeny of neoblasts [10]. The extent and duration of
mitotic responses, neoblast migration, the differentiation of
neoblast progeny and mechanisms to report successful regenera-
tive outcomes that ultimately down regulate growth responses
must exist through the whole animal. Exquisite control of these
processes is necessary, as failure would lead to aberrant/
incomplete regeneration or conversely outgrowths that disturb
normal physiology. Recent insights from careful observation of
degrowth processes has shown that the numbers of neoblast
progeny are decreased and cell death increased in response to
nutrient shortage [11]. This response, as in other animals, requires
insulin signalling [12]. It seems more than likely that other
signalling systems regulating these processes will be conserved
across animals. The extreme nature of planarian life history traits
mean that it is a simple and accessible system to identify new
regulators of this process which may prove to be evolutionarily
conserved.
Here we demonstrate this potential by identifying the PIKK
family member SMG-1 as a key regulator of planarian growth. Its
loss results in a deregulation of planarian growth leading to lethal
ectopic outgrowths as the stem cell response to injury runs out of
control. We also identify the central components of mTOR
signalling, arguably the nexus for signals controlling growth across
animals and show that the mTORC1 complex is necessary for
blastema formation and growth. We find that the novel
physiological function for SMG-1 acts antagonistically with
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mTORC1 signalling. Our findings have broad implications for
understanding regeneration, growth and cancer.
Results
Smed-smg-1 restricts the injury response and blastema
growth by regulating neoblast proliferation
In an RNAi screen attempting to identify novel signals that
regulate correct growth in Schmidtea mediterranea we identified a
gene with high identity to human SMG-1 (hSMG-1, suppressor
with morphogenetic effect on genitalia). Phylogenetic and
conserved domains analyses supported the hypothesis that this
gene is a homolog of hSMG-1 leading us to call it Smed-smg-1
(Figure 1A, Figures S1 and S2; GenBank Accession Number
JF894292). We found that Smed-smg-1 is very broadly expressed
through all planarian tissues, including neoblasts (Figure 1B and
1C). SMG-1 is the most recently described member of the
phosphoinositide 3-kinase-related kinase family (PIKKs) [13,14].
An SMG-1 homolog in C. elegans has been described as having a
role in the RNA surveillance nonsense-mediated mRNA decay
(NMD) pathway [15]. SMG-1 loss also results in lifespan extension
in C. elegans, through an activity unrelated to its role in NMD [16].
Like other PIKKs, hSMG-1 is implicated in genome surveillance
in human cells responding to stress. For example hSMG-1 is
activated by DNA damage [17], during tumour necrosis factor-a-
induced stress [18], cell cycle checkpoint signalling under oxidative
stress [19] and negatively regulates HIF-1a activity in hypoxia
[20]. Despite the fact that hSMG-1-depleted human cells display
an increased level of spontaneous DNA damage [17] the
physiological roles of SMG-1 in the absence of genotoxic stress
have not been further studied.
Planarians were injected with Smed-smg-1 dsRNA and amputat-
ed in order to observe regeneration (Figure 2A). gfp dsRNA, a
sequence not present in S. mediterranea genome, was used as control
for all RNAi experiments. Smed-smg-1(RNAi) induced regeneration
phenotypes became apparent in live animals from 7 days of
regeneration (7 dR) when blastemas displayed minimal differen-
tiation (n = 121/121) compared to controls (Figure S3). At 25 dR,
when controls had completed regeneration, ,70% of Smed-smg-
1(RNAi) planarians still had unpigmented blastemas of varying size
sometimes with apparent epidermal hyperplasia (Figure 2A, 2B),
and ,27% either displayed outgrowths/hyperplasia or had
already died after forming outgrowths (Figure 2A, 2B). Eventually,
all planarians that had abnormal blastemas progressed to form
outgrowths and died (30–38 dR; 116/121) (Figure S4). The
observation of hyperplasia and outgrowths suggested that Smed-
smg-1 might regulate neoblast proliferation. We checked the
pattern of mitotic neoblasts at different time points during
regeneration by using the Histone H3 phosphorylated at serine
10 (anti-H3P) antibody [21] (Figure 2C). We observed that Smed-
smg-1(RNAi) planarians had a hyper-proliferative pattern of
neoblast division with a higher (P,0.05) and clearly extended
(P,0.01) 6 hR mitotic peak in response to initial injury and higher
baseline levels of proliferation from 3 dR that fail to return down
to normal levels (P,0.01). Planarians were never depleted for
neoblasts (Figure 2D) and showed higher levels of proliferation
than controls even when death was imminent at 30 dR (Figure 2B).
To understand whether the higher proliferative response to
amputation in Smed-smg-1 RNAi animals was due to an increasing
number of neoblasts present before amputation, we quantified the
number of anti-H3P positive cells and the number of neoblasts
positive for Smedwi-1, a marker for neoblasts [22], before
amputation. We observed similar numbers of neoblasts (P.0.05)
suggesting that differences in proliferation and neoblast number
become apparent after amputation (Figure 2C and Figure S5).
Our data suggest that Smed-smg-1(RNAi) results in a hyper-
proliferative response after injury/amputation and that this
eventually results in lethal outgrowths. Given that Smed-smg-
1(RNAi) led to the formation of unpigmented blastemas, suggesting
a lack of terminal differentiation, we next wished to assess the
detailed dynamics of neoblasts and their progeny in relation to this
phenotype.
Smed-smg-1(RNAi) blastema growth is characterised by
an uncontrolled accumulation of cycling neoblasts and
their progeny with differentiation defects
Given the observation that Smed-smg-1(RNAi) animals showed
unpigmented blastemas at 20–25 dR (Figure 2A), we next assessed
the ability of neoblasts to differentiate. We used markers expressed
in neoblasts, recent neoblast progeny or older neoblast progeny.
Consistent with the study that originally defined these markers
[23], we could observe increasingly peripheral expression domains
for the different markers of these three cellular compartments in
20 dR control animals. Smedwi-1 (neoblast marker) is expressed
deeper in the body; Smed-NB.21.11e (early post mitotic progeny) is
expressed peripherally to Smedwi-1 and Smed-AGAT-1 (late post
mitotic progeny), which is the most peripherally expressed
(Figure 2E). In Smed-smg-1(RNAi) animals we observed an antero-
dorsal expansion of the Smedwi-1+ neoblast compartment at
anterior-facing blastemas and posterior-dorsal expansion at
posterior-facing blastemas as early as 7 dR (Figure S3) that was
even more pronounced at 20 dR (Figure 2E1–E12, Figure S6 and
Figure S7). This expansion clearly encroached on the early and
late progeny compartments (Figure 2E, Videos S1 and S2). This
expansion was corroborated by the presence of a large front of
cycling neoblasts (Smedwi-1+ cells and H3P+ cells) present around
the eyes that also reached anterior to the eyes, a region which is
Author Summary
Planarian flatworms have a remarkable ability to regener-
ate that has driven the curiosity of scientists for more than
a century. They are also able to continuously grow or
degrow their bodies, depending on food availability.
Around 25% of the cells in the planarian body are adult
stem cells, which are responsible for this incredible
plasticity. The initial response of planarians to injury is
characterised by a rapid increase in stem cell division.
Subsequently planarians form a specialised new tissue
called the regenerative blastema to replace missing
tissues. Currently, very little is known about the molecular
signals controlling the response to injury or the tight
regulation of growth. Here we discovered that a gene
called Smg-1 and the conserved mTOR signalling pathway,
a central regulator of animal growth, are both regulators of
this process. SMG-1 is required to limit and act as a brake
on the initial response to injury and ensure that it does not
run out of control, while in contrast mTOR signalling is
required to drive this process forward. Loss of SMG-1 leads
to hyperactive responses to injury and subsequent growth
that continues out of control. Eventually, these animals
form outgrowths, which display several hallmarks of
human cancers. These opposing roles suggested that
Smg-1 phenotype would require mTOR signalling, and by
reducing mTOR signalling and SMG-1 activity at the same
time we found that this was the case. We conclude that
Smg-1 is a novel regulator of regeneration and animal
growth with an antagonistic role to mTOR signalling in
planarians.
SMG-1 Restricts Growth and Stem Cell Proliferation
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Figure 1. Smed-smg-1 is a bona fide SMG-1 and is broadly expressed in the whole planarian body. A. Maximum Likelihood phylogenetic
tree of PIKK full-length proteins. Phylogeny inferred with RAxML (GTR+C+I), numbers correspond respectively to Bootstrap supports and Bayesian
inference Posterior Probabilities. A black dot indicates a clade with Bootstrap support superior to 95% and Bayesian Posterior Probabilities (PP) values
of 1,0. Values under 50% or 0.5 are not indicated. The scale bar indicates the number of changes per site. For accession numbers corresponding to
each terminal see Table S1. B. Smed-smg-1 is broadly expressed in the planarian body (n = 30/30 in three independent experiments). The right panels
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usually devoid of cycling neoblasts in normal worms [24]
(Figure 2E2, E5, E8, E11, E13, E16) and by quantifying the
number of Smedwi-1+ from the region of the eyes until the tip of
the head (P,0.001; Figure S6). Furthermore, the early and late
progeny compartments had also higher proportional volumes
than controls (Figure 2D; P,0.01), with the highest volume
being at the most anterior region of the animal in front of the
eyes (P,0.001) (Figure 2E5, E6, E11, E12, Figure S6). By using a
panel of markers of differentiated cells [22,24–28] we observed
anterior blastemas with differentiation defects, especially the
region that should contain the dorsal-most part of the brain
ganglia and the eyes (Figure 2A, 2E13–E18, 2F and Figure S8A).
This correlated with the accumulation of neoblasts and progeny
in the same areas. Similarly in the regeneration of the digestive
system, the anterior branch did not reach the level of the eyes
and the posterior branches did not reach the most posterior part,
being anastomosed instead of separated (Figure 2E15 and 2E18,
Figure S8B). We observed that the most anterior tip of the
animal displayed an ongoing lack of terminal differentiation
(Figure 2E15, E18, 2F) having been transformed into a region of
continuous growth and neoblast activity normally associated
with deeper mesenchymal tissue regions or post-blastema regions
after injury. Together our data suggests that loss of Smed-smg-1
results in neoblast hyper-proliferation that extends to tissues
normally devoid of cycling neoblasts. This in turns causes
abnormal growth due to an uncontrolled accumulation of
neoblasts and progeny, which prevent correct patterning and
differentiation in these areas. Eventually, the over proliferation
leads to hyperplasia, abnormal outgrowths and consequently
death (Figure 2G).
Smed-smg-1(RNAi) leads to lethal outgrowths which
display several hallmarks of human cancers
We wished to understand the cellular nature of events leading to
ectopic outgrowths in more detail to try and shed more light on
how smg-1might regulate these processes in normal tissue. In order
to investigate if Smed-smg-1 was also regulating normal homeostatic
control of neoblast proliferation we observed Smed-smg-1(RNAi)
animals without amputation. These animals displayed neoblast
hyper-proliferation (P,0.01) and general hyperplasia (P,0.01)
accompanied by a profound anatomical disruption (Figure 3A, 3B,
3C, 3D and Figure S9A). Control planarians had typically well-
defined monostratified epithelial cells characterised by larger
columnar dorsal epithelial cells and smaller cuboidal ventral
epithelial cells. However, the dorsal epidermis of Smed-smg-1(RNAi)
animals appeared multistratified with numerous outgrowths
causing planarians (n = 87/87) to die at around 20 days after the
last injection (Figure 3B). Significantly, we observed Smedwi1+,
histone H2B+ and anti-H3P+ neoblasts abnormally located in
outgrowths, infiltrating the epidermis, disrupting the subepidermal
nerve plexus and the integrity of the basement membrane
(Figure 3E, 3F, 3G and Video S3). However, we never observed
Smed-NB.21.11e+ (n = 0/6 planarians) and only rarely Smed-AGAT-
1+ cells (Figure S9B). As for regeneration we also observed
proliferation in front of the eyes (Figure S9C). Additionally, ventral
epithelial cells were over 20% longer along the dorsal ventral axis
than in control animals, indicative of cellular hypertrophy in a
post-mitotic cell population (Figure 3H).
As just a tiny wound is enough to start the first mitotic response
[8] one possibility would be that the homeostasis phenotype
observed is also a response to the injury caused by RNAi by
injection. To test this we performed an RNAi experiment by
feeding, which does not involve causing injury to the planarians
(Figure S10A and S10B). We observed the same phenotypic
consequences that we observed for RNAi by injection. We
observed that the increased mitotic response usually induced by
feeding planarians [29] was higher in Smed-smg-1 RNAi animals
than in controls (P,0.01) (Figure S10C). These data indicate that
the mitotic response induced by feeding is also regulated by Smed-
smg-1 suggesting that both injury and growth responses require
normal SMG-1 levels to place a brake on proliferation. Currently
the methodology of RNAi delivery makes it impossible to ascertain
whether loss of SMG-1 causes increased proliferation without an
initial stimulus, such as wounding, amputation or feeding.
Altogether these data indicate that Smed-smg-1 is necessary for
controlling the proliferation of neoblasts and spatially restricting
the cycling neoblast compartment during regeneration and
homeostasis.
Planarian mTORC1 is required for the initial response to
injury and blastema formation
mTOR signalling has been shown to control both growth and
homeostasis in a number or organisms [30–32]. Previous RNAi
experiments with homologs of PTEN in planarians, a known
suppressor of mTOR signalling, have been shown to also lead to
abnormal outgrowths thus implicating mTOR in controlling
planarian growth [33]. We first characterised all the components
of TORC1 and TORC2 in planarians (Figure 4A). We found the
three main components of mTORC1, mTOR, the regulatory-
associated protein of TOR called RAPTOR and LST8 in S.
mediterranea, which we named Smed-tor and Smed-raptor and Smed-lst8,
respectively (Figure 1, Figure 4, Figure S1, Figure S11 and Figure
S12A; GenBank Accession Numbers JF894290, JF894291 and
JN815261). We also identified the two main components of
mTORC2, RICTOR and SIN1, which we named Smed-rictor and
Smed-sin1, respectively (Figure S13A; GenBank Accession Num-
bers JN815259 and JN815260).
Consistent with their broad organismal role we observed that, in
addition to being expressed broadly in the planarian body, Smed-tor
and Smed-raptor were expressed in most neoblasts (Figure 4B and
4C). Abnormal neoblast proliferation in Smed-tor RNAi animals has
been already described [8]. Although Smed-tor(RNAi) animals were
able to close wounds after amputation, they were not able to form
blastemas, even after more than 25 dR (Figure 4D and 4E). These
animals lacked the first mitotic regeneration peak (P,0.01) and
mitotic levels during regeneration were lower than controls
(P,0.05) (Figure 4F). This difference was not due to a decrease
in the number of neoblasts present before amputation (Figure S5),
suggesting that the effects we observe are related to the control of
mitotic responses to wounding and subsequent regeneration.
Consistent with RAPTOR phenocopying TOR in other
organisms [34], Smed-raptor(RNAi) induced the same phenotype
show an in situ hybridization on 10 mm paraffin sections where the staining is shown in black-dark grey. High magnifications show expression in
gastrodermal cells (red arrows) and neurons of the brain ganglia (blue arrows). A, anterior; P, posterior. C. ISH on FACS-isolated cells for the three cell
populations already described based on sensitivity to irradiation [71]. X1 and X2 are irradiation sensitive cells and thus contain neoblasts, while Xins is
insensitive and thus formed by differentiated cells. Representative results are shown. Percentages are signal-positive cells. Smedwi-1 was used as a
positive control and neoblast marker. Smedwi-1 is mostly expressed in the X1 population [72]. Smed-smg-1 is expressed in all three populations. Scale
bars indicate 300 mm and 10 mm for single cell images.
doi:10.1371/journal.pgen.1002619.g001
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Figure 2. Smed-smg-1 is required to restrict blastema growth during regeneration. A. The cartoon shows the levels of transverse
amputation performed in the experiment (arrows) and highlights the trunk piece (dotted red circle), which was kept to follow anterior and posterior
regeneration in all the experiments. Panels show 20–25 dR trunks. Dotted red lines define the blastemas. ph indicates the pharynx. Smed-smg-1(RNAi)
animals show varying size of abnormal unpigmented blastemas with several degrees of eye differentiation displayed by the eye pigmentary cup in
the live images (black arrows) and the VC1 staining. Asterisk shows a thickened optic chiasm, the white arrow shows an extra eye as an accumulation
of unilateral photoreceptor clusters, always more anteriorly positioned than the original eyes, the yellow arrow shows abnormal axonal projections,
and the white arrowhead shows an aberrant antero-dorsal photoreceptor projection. The black arrowhead shows epidermal hyperplasia. B. Table
SMG-1 Restricts Growth and Stem Cell Proliferation
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as Smed-tor(RNAi), albeit with a weaker penetrance (Figure 4D).
Although qPCR experiments showed that RNAi experiments
downregulated Smed-lst8 expression in a similar way to Smed-raptor
after RNAi (Figure S12C), we observed a relatively weak
phenotype that was nonetheless in agreement with the phenotypes
described for Smed-tor and Smed-raptor (Figure S12B). RNAi for
TORC2 components Smed-rictor and Smed-sin1 did not show any
apparent phenotype after more than 40 days of regeneration, even
after three rounds of RNAi injections or combining RNAi of both
genes (Figure S13B). The mRNA levels were however downreg-
ulated at similar values as in Smed-raptor RNAi experiments or
Smed-smg-1 RNAi experiments (Figure S13C).
Interestingly, it has already been shown that mTOR signalling
is important for the proper balance of stem cell self-renewal and
differentiation. For instance, mTOR downregulation has been
shown to suppress embryonic stem cell self-renewal while
enhancing endodermal and mesodermal differentiation [35]. We
wanted to investigate if down-regulation of Smed-tor and Smed-
raptor, in addition to decreasing, proliferation would enhance
differentiation. We first monitored the production of differentiat-
ing neoblast progeny and found them to be as controls for Smed-tor
RNAi animals (P.0.05) and reduced to around 75% for Smed-raptor
RNAi (Figure 5A), the difference being likely due to the weaker
phenotype shown by Smed-raptor RNAi.
We next assessed if stem cell differentiation was proceeding at
the wound site. Although Smed-tor and Smed-raptor RNAi planarians
showed defects in pharynx maintenance during regeneration at
7 dR (Figure 5B–5D, Video S4 and Video S5), they were able to
restore missing structures at the wound site, but this occurred
entirely within old tissues and without making a regenerative
blastema (Figure 5C and 5D). Observation of Smed-tor and Smed-
raptor RNAi planarians demonstrated they moved in a manner
consistent with having a clear anterior to posterior polarity,
consistent with correct differentiation at wound sites (Video S4 and
S5). These results are in agreement with the observation of
progeny production and show that neoblasts can differentiate to
replace missing structures in spite of the absence of a blastema
(Figure 5C and 5D).
Together these results show that mTORC1 regulates the initial
mitotic response to injury or amputation and that loss of
mTORC1 prevents correct blastema formation. mTORC1
down-regulation does not prevent differentiation at the wound
site and missing structures can be differentiated within existing
tissue without the requirement for the formation of a regenerative
blastema. Taken together these data indicate that mTORC1 is
necessary for both proliferative response to injury and for blastema
formation and growth. Mechanisms controlling differentiation and
formation of missing tissues appear to be intact suggesting that
neither mTORC1 nor regenerative blastemas are required for
their replacement.
Smed-smg-1 and mTORC1 act antagonistically in
planarians
Given the mirrored effects of Smed-smg-1 RNAi and mTORC1
RNAi with respect to proliferation, blastema formation and
growth, and differentiation we wished to assess if Smed-smg-1
phenotype manifestation required mTORC1 components or vice
versa.
We performed double RNAi experiments with Smed-smg-1 and
mTORC1 components. Double RNAi experiments combining
Smed-smg-1(RNAi) with either Smed-tor(RNAi), Smed-raptor(RNAi) or
Smed-lst8(RNAi) all showed the phenotype of Smed-tor/Smed-raptor/
Smed-lst8. Double RNAi with Smed-smg-1/gfp (RNAi) only displayed
the Smed-smg-1(RNAi) phenotype (Figure 6A, 6B and Figure S12B).
We performed qPCR experiments to confirm that the mRNA
levels of Smed-smg-1 and planarian mTORC1 components were
downregulated to similar values in both single and double RNAi
experiments (P.0.05) (Figure 6C and Figure S12C). These results
indicate that Smed-tor, Smed-raptor and Smed-lst8 function are
required for Smed-smg-1(RNAi) to drive uncontrolled growth.
mTOR signalling has been shown to be a critical pathway
involved in tumour growth being the main target in the
development of anti-cancer therapies. The macrolide rapamycin
is a natural compound that was discovered as the first inhibitor of
mTORC1. Rapamycin has shown promising results against some
cancers like renal cell carcinoma or where PTEN is deleted, like
endometrial cancers [36,37]. Interestingly, it has also been shown
to prevent the abnormalities produced by Smed-PTEN loss of
function in planarians [33]. Therefore, rapamycin treatment
experiments represent an extra tool for showing that the
phenotype resulting from loss of Smed-smg-1 results from overactive
mTOR signalling. We first injected planarians with daily doses of
rapamycin (20 nM, 30 nM or 40 nM) to check if rapamycin alone
can affect proliferation during homeostasis and regeneration and
mimic the effect of RNAi of planarian mTORC1 components. We
quantified H3P+ cells 2 weeks after the daily treatment. Although
we could not observe any morphological abnormalities, planarians
displayed a significant decrease (P,0.05) in basal proliferation
when treated with 30 nM or 40 nM rapamycin (Figure 7A).
Although planarians formed normal regenerative blastemas and
did not display any external phenotypes we found that the low
dose of 20 nM of rapamycin was sufficient to decrease the mitotic
levels with respect to DMSO treated controls at 6 h of
regeneration. Rapamycin treated animals did however still display
summarising the phenotypes observed in trunks at 25 dR; hyperplasia refers to epidermal hyperplasia observed in live animals. C, D. Mitotic numbers
during different time points of regeneration and volume of the different neoblast compartments at 20 dR, respectively. Error bars are s.d from the
mean and asterisks indicate P,0.05 (one asterisk) or P,0.01 (two asterisks) using two-tailed Student’s test with equal sample variance. C. n$5
planarians per time point in at least two independent experiments; D. n$4. E. Panels show maximum confocal projections for the dorsal-most
sections (1, 7, 4 and 10), the medial sections (2, 8, 5 and 11) and the ventral-most sections (3, 9, 6 and 12) of 20 d anterior regenerating trunks.
Asterisks indicate the position of the eyes. Panels show the distribution of neoblasts (cat-1), neoblast early progeny (cat-2) and neoblast late progeny
(cat-3) markers in controls versus Smed-smg-1(RNAi) animals. The inset in 8 and 11 show the presence of cat-1 and H3P+ cells in the cat-2 and cat-3
compartment in front of the eyes in Smed-smg-1(RNAi) animals. Strips represent confocal XZ or YZ projections (D is dorsal and V is ventral)
demonstrating a greater volume of neoblasts and progeny, an accumulation of cat-1 cells dorsal to the brain ganglia (X2 and Y1) and a higher
accumulation of cat-3 at the anterior tip of the planarian (X1, Y1, Y2) in Smed-smg-1(RNAi) compared to controls. n$4. Lower panels show H3P+ cells
(panels 13 and 16, blue arrow) in front of the eyes (maximum confocal projection; n = 4/8), a very undeveloped brain labelled by anti-SYNAPSIN
staining (panels 14 and 17; dorsal maximum confocal projection), an anterior gut branch (seen in BCAT-2 staining; maximum projection) aberrantly
located with respect to the position of the eyes (n = 4/6, the white arrow indicates the most anterior level reached by the anterior gut branch) and the
epithelium of protonephridial tubules stained by anti-BCAT-2 not reaching the tip of the planarian (panels 15 and 18; white arrow head; n = 6/6) in
Smed-smg-1(RNAi) animals. F. Panels show maximum confocal projections of 20 d anterior regenerating trunks. The tip of the blastema shows
minimal differentiation of muscle cells (stained with anti-TMUS13) in Smed-smg-1(RNAi) planarians. n = 3/3. G. Cartoons summarising the phenotype
observed during anterior regeneration of 25 dR trunks. Scale bars represent 300 mm. Scale bars in (E) high magnification images represent 50 mm.
doi:10.1371/journal.pgen.1002619.g002
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a significant mitotic response to amputation compared to the pre-
amputation levels of proliferation (Figure 7A, P,0.01). Our data
indicates that rapamycin treatment alone affects basal neoblast
proliferation but does not specifically eliminate the mitotic
response to injury or the normal blastema formation displayed
in rapamycin treated planarians.
We next combined daily doses of rapamycin with RNAi
experiments. Planarians were injected with rapamycin two days
previous to the RNAi injections (gfp or Smed-smg-1), with
amputation at day 8 after the first RNAi injection and continuing
rapamycin injections stopped on day 25 when outgrowths were
obvious in control DMSO+Smed-smg-1 RNAi injected planarians.
Some planarians were fixed at 20 h after amputation to observe
proliferation at a time when the levels of proliferation are at the
maximum in Smed-smg-1 RNAi animals (Figure 2C). We observed
that 20 nM rapamycin was able to decrease proliferation of Smed-
smg-1 RNAi animals to normal values (P.0.05) (Figure 7B). Smed-
smg-1 RNAi planarians treated with rapamycin showed the same
unpigmented blastema as DMSO treated animals. However, 50%
of the planarians treated with 20 or 30 nM rapamycin and more
than 60% of the planarians treated with 40 nM rapamycin showed
some differentiation in the blastemas and survived as long as the
DMSO+gfp treated animals (Figure 7C). Our data indicates that
rapamycin is able to reverse the effects of Smed-smg-1(RNAi) by
decreasing proliferation and preventing the formation of out-
growths in about 50% of Smed-smg-1(RNAi) animals.
Figure 3. Smed-smg-1(RNAi) leads to lethal outgrowths during planarian homeostasis. A, B. Panels and table show Smed-smg-1(RNAi)
phenotype progression compared to controls. Black arrows show epidermal hyperplasia and green arrows show outgrowths. B. Progression of the
RNAi phenotypic characteristics at various time points (days) after the last injection. C. Mitotic numbers at 9 days after the last injection (n$6 per
condition). D. Volume of nuclei in 10 mm paraffin sections. Equivalent regions for at least 6 different planarians per condition were measured. E. Single
confocal section of H3P+ cells (arrows) observed in an outgrowth (arrow head) for a Smed-smg-1(RNAi) animal at 9 days after the last injection (n = 7/8
displaying outgrowths had mitotic cells visible; see Video S3 for a whole worm view). F. The cartoons show how the sagittal paraffin sections were
performed. Panels display the region of the orange square in the cartoons. Panels are maximum confocal projections of slices performed on 10 mm
paraffin sections showing a monostratified dorsal and ventral epidermis in control animals and a multistratified dorsal epidermis in the case of Smed-
smg-1 (RNAi) animals (yellow arrowheads). Smed-smg-1(RNAi) animals show Smedwi-1+ cells in outgrowths (white arrows; n = 2/4 planarians), h2b+
cells infiltrating to the epidermis (green arrow) and disrupting the integrity of the basement membrane (dotted white line) and at the multilayered
epidermis (white arrows; n = 3/4 planarians). G. Dorsal-most confocal sections of the planarian head showing the subepidermal nerve plexus stained
by synapsin where several disruptions can be observed in Smed-smg-1(RNAi) animals (arrows). Asterisks indicate the position of the eyes. H. The
panels and graph show that Smed-smg-1(RNAi) animals have bigger ventral epidermal cells (hypertrophy) than controls. Panels display the ventral
epidermis (deconvolved confocal maximum projections of slices performed on 10 mm paraffin sections). Double arrows show the distance from the
basement membrane until the outer membrane of the epidermal cells (stained with anti-BCAT-2). See Material and methods for details about
quantification method. Error bars for all the graphs are s.d from the mean and asterisks indicate P,0.01 using two-tailed Student’s test with equal
sample variance. Black scale bars indicate 300 mm and white scale bars indicate 50 mm.
doi:10.1371/journal.pgen.1002619.g003
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Figure 4. Smed-tor and Smed-raptor are necessary for the response to injury and blastema growth. A. Tables that summarise the
components of mTORC1 and mTORC2 found in S. mediterranea. +++ indicates strong phenotype, ++ indicates weak phenotype, + indicates very weak
phenotype, 2 indicates no phenotype after RNAi experiments. B. Smed-tor and Smed-raptor are broadly expressed in the planarian body. A high
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Discussion
mTOR signalling has central control of cell growth and
proliferation in all eukaryotes analyzed so far [31]. Consistent
with mTOR signalling regulating growth, human genetic defects
that are associated with upregulated mTOR activity manifest as
abnormal cell growth and proliferation. Indeed, many negative
regulators of mTOR signalling are known human tumour
suppressors. As a result mTOR signalling is currently the most
targeted signalling pathway in drug development for the treatment
of cancers.
It is known that mTOR signalling is essential for the early
developmental programmes of metazoans. For instance Drosophila
or C. elegans TOR loss-of-function mutations leads to develop-
mental arrest [38,39] and homozygous mTOR2/2 mouse
embryos die shortly after implantation due to impaired cell
proliferation in both embryonic and extra-embryonic compart-
ments [40–42]. mTOR itself forms the core of two different
complexes and of these TOR complex 1 is thought to be
responsible for regulating cell growth and proliferation [31]. We
show that planarian Smed-tor, Smed-raptor and Smed-lst8 homologs of
TOR, RAPTOR and LST8 respectively and members of TORC1,
are necessary for blastema growth during regeneration (Figure 4
and Figure S12). RNAi experiments for Smed-tor and Smed-raptor
result in a lack of the first mitotic peak and blastema during
regeneration and show lower general levels of proliferation
through the whole regenerative process. Recently it has been
shown that planarian amputation triggers two peaks in neoblast
mitoses early in regeneration. The first mitotic peak is a body-wide
response to any injury and the second response is induced only
when injury results in missing tissue [8]. RNAi experiments for
Smed-tor or Smed-raptor show that these animals lack the first mitotic
peak of regeneration and thus lack a response to injury. Our results
suggest both that the first mitotic peak is necessary for blastema
formation and that this first mitotic peak requires the activation of
mTOR signalling. The second mitotic peak is a response to
missing tissue and it triggers neoblast differentiation [8]. Although
reduced, Smed-tor and Smed-raptor RNAi planarians did show a
second mitotic peak (Figure 4F) and some ability to restore missing
structures at the wound site within old tissues without making a
blastema (Figure 5C and 5D). The role of mTOR signalling in
regeneration [43] and in the regulation of stem cells [44,45] is just
starting to be elucidated. Our results support a key role for mTOR
signalling in controlling stem cell proliferation and growth during
regeneration.
In this study we have also characterised the planarian homolog
of hSMG-1. SMG-1 has widely been linked to NMD [15] and
SMG-1 has been also shown to have functions independent of
NMD, mostly related to cellular stress responses [46]. However, its
physiological roles are not yet well understood and only few studies
have been performed in vivo. In C. elegans and Drosophila Smg-1 is
dispensable for survival and development while other components
of NMD in these organisms are essential [15,47]. In mice, SMG-1
is dispensable for implantation and gastrulation but is critical
thereafter for basic differentiation, a phenotype presumed to
reflect its function in mediating NMD [48].
Here we have showed that Smed-smg-1(RNAi) results in higher
and extended mitotic responses to injury at 6 hR. Following this
levels of proliferation remain raised and this contributes to these
animals undergoing continuous growth within the blastema. Cells
fail to terminally differentiate, proliferating cells remain in
aberrantly high numbers and accumulate inappropriately within
the blastema. Thus, Smed-smg-1 in contrast to planarian mTORC1
components is required for restricting the response to amputation
and the growth of the blastema. Our data suggest that
uncontrolled growth occurs in a gradient along the dorso-ventral
axis, increasing from ventral to dorsal regions. Several indications
support this observation. In anterior regenerating blastemas,
cycling neoblasts accumulate initially in the ventral part of the
animal, and this is the only area in which some correct terminal
differentiation is observed. In more dorsal blastema regions less
differentiation is observed. Instead, we observe the presence of
cycling neoblasts invading the dorsal-most part of the brain, a lack
of terminally differentiated cells and accumulation of neoblast
progeny. This continuous growth of the blastema eventually leads
to abnormal and lethal outgrowths, with all the outgrowths initially
formed at the dorsal level consisting of cycling neoblasts and
progeny. These observations suggest that normal planarian growth
may follow a ventral to dorsal pattern. During homeostasis, we
observed uncontrolled proliferation that also results in lethal
ectopic outgrowths. To investigate the possibility that the
phenotype observed during homeostasis is also a response to the
injury caused after RNAi injections we performed experiments of
RNAi by feeding. However, we also observed that Smed-smg-1
regulates the mitotic response to feeding. Thus we were unable to
ascertain whether or not Smed-smg-1 also has a role as a
homeostatic brake for growth control or whether it is specific to
providing a brake to stimuli that promote growth. Nevertheless, we
have uncovered a new role for Smg-1 in stem cell regulation,
regeneration and growth. It will be very interesting to investigate
the possible evolutionary conservation of these novel roles in other
systems.
It has already been shown that planarians provide a model
system with which to study tumour suppression and adult stem cell
lineages in vivo. RNAi experiments on the planarian homologs of
several known human suppressors such as PTEN or p53 have also
shown to lead to outgrowths [33,49]. Although the Smed-smg-
1(RNAi) phenotype shares some characteristics with Smed-PTEN or
Smed-p53 such as hyper-proliferation, hyperplasia and breakdown
of the sub-epithelial basement membrane that surrounds the
animal, it also has characteristics not previously described for
magnification of the head region (blue square) shows that Smed-tor is also expressed in a subset of neurons in the brain ganglia (red arrows) (n = 30/
30 in three independent experiments). C. ISH on FACS-isolated cells. Representative results are shown. Percentages are signal-positive cells. Smedwi-1
was used as a positive control and neoblast marker. Smed-tor and Smed-raptor are expressed in all three populations. D. Table that summarises the
phenotypes observed in trunks at 4 dR for Smed-tor and 3 dR for Smed-raptor. BLST indicates blastema. Phenotype classification is according to
previous published data [63]. E. Panels show representative planarians at different times of regeneration. Smed-tor(RNAi) planarians either show a
small blastema (the biggest blastema observed is shown (BLST(0–1.5) or no blastema at all. Smed-raptor(RNAi) show smaller blastemas than controls
(the biggest blastema observed is shown (BLST(0–1.5). The blastema does not grow further during regeneration, compared to controls. Planarians
never showed signs of ventral curling or regression, typical features observed when abrogating genes expressed in neoblasts [22,24] and were never
depleted of neoblasts. The blue square represents the area of high magnification. The dotted red line defines the blastema. F. Mitotic numbers during
different time points of regeneration and representative images showing H3P staining. Error bars are s.d from the mean and asterisks indicate P,0.05
(one asterisk) or P,0.01 (two asterisks) using two-tailed Student’s test with equal sample variance (n$5 planarians per time point in at least two
independent experiments). Scale bars indicate 300 mm in B, 50 mm in B high magnification, 10 mm in the isolated cells in C, 300 mm in E and 150 mm
in the E high magnifications.
doi:10.1371/journal.pgen.1002619.g004
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Figure 5. Smed-tor and Smed-raptor show similar levels of neoblast progeny as controls and are able to differentiate structures at
anterior wounds. A. Relative expression of cat-2 marker Smed-NB.21.11e and cat-3 marker Smed-AGAT-1 at 7 days of regeneration after either Smed-
tor or Smed-raptor RNAi experiments. Expression levels are relative to gfp RNAi injected animals (dotted line). Error bars are s.d from the mean.
Asterisks indicate P,0.05 (one asterisk), P,0.01 (two asterisks) and ns indicates ‘‘not significant’’ using two-tailed Student’s test with equal sample
variance and relative to expression in control animals. B. The cartoon on the left is a representation of the central nervous system (CNS in blue), the
digestive system (brown) and the pharynx (yellow) in planarians. The cartoon on the right shows the levels of transverse amputation performed in
the experiment (arrows) and highlights the trunk piece (dotted red circle), which was kept to follow anterior and posterior regeneration in all the
experiments. C. The panels show staining for different markers of differentiation in the anterior wounds in control and Smed-tor RNAi animals. Anti-
PHOSPHO-TYROSINE labels the CNS, digestive system, pharynx and eyes. The arrows highlight the presence of brain ganglia in both control and
Smed-tor RNAi at anterior wounds in 12 dR trunks. Anti-SYNAPSIN labels the synapses at the CNS. The white square indicates that this region is
magnified in the panels in the right and highlights the presence of brain ganglia in both control and Smed-tor, however underdeveloped in Smed-tor
RNAi 7 dR trunks. bg, brain ganglia; vnc, ventral nerve cords. Anti-VC1 staining shows that controls and Smed-tor RNAi animals have differentiated
eyes at the anterior wound site at 12 dR trunks. Anti-BCAT-2 staining shows that the lumen of the pharynx in Smed-tor RNAi animals is reduced
(double arrow) compared to controls (arrow). D. Panels show 15 dR trunks. The panels show staining for anti-PHOSPHO-TYROSINE as a marker for
CNS, digestive system and eyes in the anterior wounds of control and Smed-raptor RNAi animals. The white square indicates that this region is
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other planarian RNAi phenotypes. Firstly, we observe the
presence of cycling neoblasts in front of the eyes, a region devoid
of neoblasts. Secondly we observe hypertrophy of the ventral
epidermis.
We describe almost polar opposite roles for planarian
mTORC1 and Smed-smg-1 in planarian regeneration. Firstly,
mTORC1 and Smed-smg-1 have opposing effects on proliferation
and blastema growth (Figure 2, Figure 4). Secondly, we found that
while Smed-tor RNAi maintains differentiation at the wound site in
the absence of blastema formation, terminal differentiation is
impeded in Smed-smg-1 RNAi animals (Figure 2, Figure 5).
Combinatorial RNAi experiments showed the Smed-smg-1(RNAi)
uncontrolled growth requires mTOR signalling to manifest
(Figure 6). Supporting these results, experiments combining
rapamycin and RNAi also showed that rapamycin is able to
prevent the outgrowths and increase the survival rate of Smed-smg-1
RNAi planarians in about 50% of animals. While these
experiments confirm that loss of mTORC1 generally inhibits
growth it also raises the possibility that Smed-smg-1 has either a
direct or indirect interaction with mTOR signalling. The broad
expression patterns of Smed-smg-1, Smed-tor and Smed-raptor in the
planarian body, with similar distributions of expression in
neoblasts, progeny and differentiated cells also suggests this is a
possibility. Future genetic and biochemical work in cell lines and
other models systems will help elucidate the relationship between
SMG-1 and mTORC1 signalling.
Previously published data showed that rapamycin does not
affect basal proliferation in planarians [33]. However, only
homeostatic planarians were tested injecting doses of 20 nM
rapamycin. We also found that 20 nM does not affect proliferation
magnified in the panels in the right and highlights the presence of brain ganglia in both control and Smed-raptor RNAi animals (arrows), however
underdeveloped in Smed-raptor RNAi animals (10/10). Arrowheads indicate the presence of eyes. The asterisk indicates the position of the pharynx,
which is disorganized in Smed-raptor RNAi animals compared to controls (7/10). Scale bars indicate 300 mm.
doi:10.1371/journal.pgen.1002619.g005
Figure 6. mTORC1 is necessary for Smed-smg-1 RNAi phenotype. A. Table summarising the phenotypes observed after combinatorial RNAi
experiments of Smed-smg-1 with the members of TORC1. B. Panels show that double RNAi experiments of Smed-smg-1 with either Smed-tor or Smed-
raptor lead to lack of blastema formation, the same phenotype that is obtained after RNAi of either Smed-tor or Smed-raptor with gfp. Red dotted lines
define the blastema. Arrows indicate outgrowths. C. Relative expression of Smed-smg-1, Smed-tor and Smed-raptor at 7 days of regeneration after
single or double RNAi experiments. Expression levels are relative to gfp RNAi injected animals (dotted line). Similar levels of down regulation for the
different genes are observed in single or double RNAi experiments (P.0.05). Error bars are s.d from the mean and asterisks indicate P,0.05 (one
asterisk) or P,0.01 (two asterisks) or P,0.001 (three asterisks) using two-tailed Student’s test with equal sample variance and relative to expression in
control animals. Scale bars indicate 300 mm.
doi:10.1371/journal.pgen.1002619.g006
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during homeostasis. However, already 20 nM rapamycin was able
to significantly decrease proliferation in regenerating planarians
while 30 and 40 nM rapamycin doses reduced proliferation in
both homeostatic and regenerating planarians. We observed
differences between the rapamycin treatment and the inhibition
of mTORC1 in planarians. Rapamycin was able to decrease the
general levels of planarian proliferation without abolishing the
mitotic response to injury and did not affect blastema formation
and growth. Significantly, rapamycin does not completely inhibit
mTORC1 activity in mammalian cells and clearly affects some
TORC1 targets more than others, depending on cell type and
context [50–53].
Altogether our results indicate a novel function for SMG-1. Our
findings support a model where SMG-1 acts as break on growth
and proliferation. The altered patterns of proliferation and the
presence of abnormal invasive cells disrupting the epithelial-
mesenchymal interactions we have observed in Smed-smg-1(RNAi)
planarians are hallmarks in the early progression of most human
cancers. To date reports from the COSMIC database describe
mutations of SMG-1 in human breast cancer cell lines and hSMG-
1 RNA is detected only at low levels in lung carcinoma and
melanoma cell lines [14,20]. These reports together with our new
functional findings indicate SMG-1 is likely to be a potential
human tumour suppressor gene product. Given this new
physiological role for Smg-1 it will now be important to investigate
whether mutations in hSMG-1 results in cell growth and/or
invasiveness contributing to the aetiology of cancers.
The defects observed after Smed-smg-1(RNAi) may not result
from defects in the previously characterised role in the NMD
pathway. Very recently, a planarian RNAi screen has shown that
several components of the NMD pathway in planarians either
show no phenotype after RNAi or show a different one to that
observed in Smed-smg-1(RNAi) [54]. This suggests that the
phenotypes observed for Smed-smg-1 may be independent of
NMD, alternatively our results may reflect unknown roles for a
subset of NMD activities requiring SMG-1 but not other NMD
components. A precise understanding of the mechanism(s) by
which SMG-1 affects impacts growth and proliferation in
physiological conditions may be important in the development
of novel cancer therapies and other diseases. The identification of
Figure 7. Rapamycin decreases neoblast proliferation and increases the survival rate in Smed-smg-1 RNAi animals. A. Number of H3P
positive cells per mm2 of un-cut planarians or 6 hR planarians that were previously treated with daily injections of DMSO, 20 nM rapamycin, 30 nM
rapamycin or 40 nM rapamycin during 2 weeks. Error bars are s.d from the mean, the asterisk indicate P,0.05 while ns indicates ‘‘not significant’’
(P.0.05) using two-tailed Student’s test with equal sample variance relative to the corresponding DMSO treated planarians. 6 hR shows an increased
mitotic peak respect to the pre-cut condition despite the treatments (P,0.01). No significant differences (P.0.05) are observed either between the
30 nM and 40 nM rapamycin treatment in the pre-cut planarians or between the different rapamycin treatments in the 6 hR planarians. B. Number of
H3P positive cells per mm2 in control RNAi and Smed-smg-1 RNAi planarians at 20 hR that were treated with daily injections of DMSO, 20 nM
rapamycin, 30 nM rapamycin or 40 nM rapamycin. Outside the bars two asterisks (p,0.01) show significant differences while ns (p.0.05) shows no
significant differences relative to the control RNAi animals. The asterisks inside the blue bars show significance relative to the 20 hR control RNAi
worms DMSO treated whereas inside the red bars the significance is shown relative to the 20 hR Smed-smg-1 RNAi worms DMSO treated. Error bars
are s.d from the mean and asterisks indicate P,0.05 (one asterisk) or P,0.01 (two asterisks) or P.0.05 (ns) using two-tailed Student’s test with equal
sample variance.$8 planarians per time point. C. Kaplan-Meier curves demonstrate increased survival of Smed-smg-1 RNAi animals when treated with
20 nM, 30 nM or 40 nM rapamycin. Four asterisks indicate p,0.0001 with log-rank analysis of survival curves. Representative images of surviving
animals after Smed-smg-1 RNAi and treated with 40 nM rapamycin are shown at 45 dR. Scale bars indicate 300 mm.
doi:10.1371/journal.pgen.1002619.g007
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a candidate tumour suppressive function for SMG-1 further
validates the planarian system as a source of novel insights relevant
to human disease processes.
Materials and Methods
Animals
Planarians used in this work belong to the species Schmidtea
mediterranea asexual strain and were maintained at 19uC in tap
water treated with activated charcoal and buffered with 0.5 ml/L
1 M NaHCO3. Planarians were fed organic veal liver and starved
for at least one week prior to experiments.
Planarian gene identification and phylogenetic analysis
Protein sequences from different organisms (from yeast to
human) were used to find planarian homologs from the S.
mediterranea genome database and transcriptome [55,56] via
tBLASTn searches. Planarian homologs were then used for
reciprocal BLAST to verify homology. We found three contigs
encoding Smed-smg-1 (Contig 8142, Contig 8791, Contig 7718),
one contig encoding Smed-tor (Contig 497), two contigs encoding
Smed-raptor (Contig 424 and Contig 569) one contig encoding Smed-
lst8 (Contig 55), 4 contigs encoding Smed-rictor (Contig 2311,
Contig 44763, Contig 91234 and Contig 10206) and 4 contigs
encoding Smed-sin1 (Contig 41273, Contig 15360, Contig 23280
and Contig 15360). Protein domains were predicted using
InterProScan (EMBL-EBI) and PFAM (Wellcome Trust Sanger
Institute). GenBank accession numbers for the genes reported here
are: JF894292 Smed-smg-1, JF894291 Smed-tor, JF894290 Smed-
raptor, JN815261 Smed-lst8, JN815259 Smed-rictor and JN815260
Smed-sin1. Using as queries previously described SMG-1 and TOR
proteins from various metazoans, we performed tBLASTN and
BLASTP searches against genomes and EST datasets of different
organisms. Each gene was aligned independently using MAFFT
v.6.850 [57], with the EINSI strategy. The resulting alignments
were checked with Bioedit v. 7.0.9.0 [58] and edited with
Geneious (available from http://www.geneious.com). For the
full-length gene alignments of RAPTOR and the PIKK family,
regions of ambiguous alignment were removed by Gblocks v.0.91b
[59] using the ‘‘relaxed’’ options from the server version. Bayesian
inference trees were inferred with a parallelized version of
MrBayes v.3.1.2 [60], running 1,000,000 generations in 2
independent analyses with a sample frequency of 1 in 1000; the
evolutionary model used in MrBayes was WAG+C+I (4 gamma
categories+1 invariable). To obtain the consensus tree and
bayesian inference supports, 10% of the generations were removed
to discard trees sampled before likelihood values had reached a
plateau. Maximum likelihood trees were inferred with RAxML
v.7.2.6 [61], ran using the model LG+C+I (4 gamma categories+1
invariable); a random topology was used as starting tree and 1,000
bootstrap replicates were obtained.
Planarian RNAi experiments
We generated 400 bp–700 bp templates with T7 promoters
appended to both strands from Smed-smg-1, Smed-tor, Smed-raptor,
Smed-lst8, Smed-rictor and Smed-sin1. We confirmed the single gene
specificity of the chosen templates by BLAST search against the













Double-stranded RNA (dsRNA) was synthesized by in vitro
transcription (Roche) and injected into planarians as described
previously [62]. All animals were injected ventrally at different
pre- and post-pharyngeal positions to rule out the possibility that
the defects observed were related to the place of injection. Control
animals were always injected with GFP dsRNA, a sequence not
present in the planarian genome. Different schedules of RNAi
injections were tried until a phenotype was observed. For Smed-
smg-1 RNAi regeneration experiments planarians were injected
following the standard schedule of three consecutive days of
injections and amputated five days after the last injection (one
round of injections) [62]. For Smed-smg-1 RNAi homeostasis
experiments, planarians were injected following the standard
schedule of three consecutive days of injections and two weeks
after the first injection were injected again for other three
consecutive days. Smed-tor, Smed-raptor and Smed-lst8 required two
rounds of injections with a gap of 10–14 days of regeneration after
the first amputation and before starting the second round of
injections. For Smed-rictor and Smed-sin1, three rounds of injections
with a gap of 14 days of regeneration after every amputation did
not give any phenotype. Because of the requirement of two rounds
of injections for Smed-tor, Smed-raptor and Smed-lst8 double injections
of Smed-tor/Smed-smg-1(RNAi), Smed-raptor/Smed-smg-1(RNAi) and
Smed-lst8/Smed-smg-1(RNAi) were performed single for Smed-tor/
Smed-raptor/Smed-lst8 during the first round and double with Smed-
smg-1 during the second round. Planarians were always amputated
at the pre and post-pharynx level to observe regeneration. For
simultaneous silencing of two genes, dsRNAs were proportionally
diluted and animals with the same dose of each single dsRNA were
injected in parallel as controls, for instance for the GFP/Smed-smg-
1(RNAi), 1/2 GFP dsRNA+1/2 Smed-smg-1 dsRNA was injected
whereas a double dose of GFP was used for the controls (GFP/
GFP(RNAi). To rule out that the phenotype observed was in part
due to the starvation process of the worms during the long
duration of the RNAi schedules, all the experiments involving
Smed-tor or Smed-raptor were also performed feeding the worms 6–7
days after every amputation and showed the same RNAi
phenotypes as during starvation.
dsRNAs for feeding were generated and fed to planarians as
described previously [63]. Control animals were fed bacteria
containing gfp cloned into the pPR242 vector [63]. The same
region of the genes used for the injection experiments was used for
the feeding experiments. Planarians were fed every 3 days a total
of four times. In the regenerating experiments planarians were
amputated 2 days after the last feeding in the same way as in the
injection experiments. Only two feedings were delivered to the
planarians to be analysed for the proliferation response to feeding.
Real-time PCR
RNA was extracted using Trizol reagent (Invitrogen). cDNA
was obtained from 2 mg of total RNA by using MMLV Reverse
Transcriptase (Promega). Elongation Factor 2 (EF2) was used as
an internal control. Two qPCRs per sample were performed. Each
qPCR was performed with two biological replicates. Five animals
were used per replicate, and each sample was replicated three
times in each real-time PCR experiment. PCR reactions were
performed using the SensiMix SYBR No-ROX Kit (Bioline).
Reactions were aliquoted using a Corbett Robot (Corbett
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Robotics) and analysed with a Rotor Gene 6000 (Corbett,
Qiagen). qPCR oligos for Smed-NB.21.11e and Smed-AGAT-1 were
used as already described [23]. The following gene specific oligos
were designed from non-overlapping regions of the gene that were













Planarian in situ hybridization (ISH)
Digoxigenin-labelled RNA probes and fluorescein-labelled
RNA probes were prepared by using an in vitro labelling kit
(Roche, Basel, Switzerland). Single and double whole mount ISH
and on paraffin sections were carried out as described previously
[64–68]. Planarian ISH on dissociated cells were performed as
previously described [69] and developed with NBT/BCIP.
Planarian immunohistochemistry
Whole-mount immunohistochemistry was carried out as
described elsewhere [70]. The following antibodies were used:
anti-VC-1 [28], specific for planarian photosensitive cells (diluted
1/15,000); anti-SYNORF1 or anti-SYNAPSIN used as a pan-
neural marker [26] (diluted 1/25, Developmental Studies
Hybridoma Bank); anti-BCAT-2 [25], which labels the membrane
of epithelial cells (diluted 1/2000); anti-TMUS13 [27], specific for
myosin heavy chain (diluted 1/20); anti-Histone H3 phosphory-
lated at serine 10 [21] to detect mitotic neoblasts (diluted 1/500,
Millipore) and anti-phospho-tyrosine [70] a neural marker that
also labels the digestive system (diluted 1/200, Cell Signalling
Technology, NEB). Alexa488-conjugated goat anti-mouse and
Alexa568-conjugated goat anti-rabbit were used as secondary
antibodies (Molecular Probes; diluted 1/400 and 1/100 respec-
tively). Cavity slides were used to preserve the morphology of the
outgrowths.
Planarian cell sorting
Planarian cells from X1, X2 and Xins populations were isolated
by fluorescence-activated cell sorting, using a Beckman-Coulter
Ultra flow as previously described [71].
Rapamycin treatment
Rapamycin treatment was performed as previously described
[33].
Imaging and quantification
Bright field and live images were observed through a Zeiss
Discovery V8 (Carl Zeiss) or a Leica MZ16F (Leica) stereomicro-
scope and a Nikon Eclipse 80i microscope and recorded on a
AxioCam MRC (Carl Zeiss), a Leica DFC 300Fx camera (Leica)
or a Hamamatsu Orca-ER. Confocal laser scanning microscopy
was performed for fluorescent samples with a Leica SP2 confocal
microscope (CLSM) (Leica). Images were processed using ImageJ
1.43l or Adobe Photoshop CS5 software and compositions done
on Adobe Illustrator CS5. Smedwi-1+, Smed-NB.21.11e+ or Smed-
AGAT-1+ voxels or Smedwi-1+ cells were quantified by Volocity
(Perkin Elmer) using confocal stacks deconvolved by the same
program. Smedwi-1+ cells were quantified in equivalent confocal
stacks of 0.035 mm2 in two different regions of the planarian: just
in front of the pharynx and immediately posterior to the pharynx.
Position of the eyes in Figure 2E was determined either by a white
field image, the background of Hoechst in the eyes, for being
negative when staining with cat-2 and cat-3 markers or for being
positive to the marker anti-VC1 [28]. Z-projections and 3D
reconstructive videos were also performed in Volocity after
deconvolution. H3P quantifications were done on whole planarian
confocal stacks and using the Object Counter 3D pluggin from
ImageJ 1.43l. Hoechst+ voxels were quantified using the Voxel
Counter pluggin from ImageJ. The length of ventral epidermal
cells was calculated with ImageJ as the average of at least 8
different points of confocal stacks deconvolved using Volocity for
at least 4 planarians. For all graphs, error bars represent standard
deviation of the mean (sd) and asterisks indicate P,0.05 (one
asterisk) or P,0.01 (two asterisks) using two-tailed Student’s t-tests
with equal sample variance.
Accession numbers
All sequences associated with this study have been deposited in
GenBank and have accession numbers JF894290 to JF894292 and
JN815259 to JN815261.
Supporting Information
Figure S1 SMED-SMG-1, the homolog of hSMG-1, and
SMED-TOR, the homolog of mTOR, are members of the PIKK
family of proteins. A. Schematic drawing of the domains present in
all the members of the PIKK family of proteins. The proteins
displayed are the ones present in humans. B. Maximum
Likelihood phylogenetic tree of the PIKK+FATC domain in
PIKK proteins. Phylogeny inferred with RAxML (GTR+C+I),
numbers correspond respectively to Bootstrap supports and
Bayesian inference Posterior Probabilities. A black dot indicates
a clade with Bootstrap support superior to 95% and Bayesian
Posterior Probabilities (PP) values of 1,0. Values under 50% or 0.5
are not indicated. The scale bar indicates the number of changes
per site. For accession numbers corresponding to each terminal see
Table S1.
(PDF)
Figure S2 Smed-smg-1 is a bona fide SMG-1. A. Schematic
illustration of the domains present on SMED-SMG-1 compared to
hSMG-1. B. Multiple alignment (Blosum 62) for the FRB, PIKK
and FATC domains of SMG-1 from several organisms. The
critical tryptophan residue required for mTOR kinase activity [14]
is conserved in SMG-1 indicated with an asterisk in the FRB
alignment. hSMG-1 contains several highly conserved motifs
found in all PIK-related kinases [13,14]. A conserved ATP-
binding site indicated by the asterisk in the PIKK domain is
conserved in all the SMG-1 proteins from the different organisms
displayed and motif I and motif II sites within the catalytic domain
indicated by the blue lines are also conserved in all the SMG-1
proteins. Residues, whose substitution decreases hSMG-1 kinase
activity, are labelled with an asterisk in the FATC alignment and
are conserved in all the organisms displayed.
(PDF)
Figure S3 Smed-smg-1 is required for correct blastema growth
and to restrict the category 1 compartment during regeneration. A.
The cartoon shows the levels of transverse amputation performed
in the experiment (arrows) and highlights the trunk piece (dotted
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yellow circle), which was kept to follow anterior and posterior
regeneration in all the experiments. B. Panels show 7 dR trunks.
Dotted red lines define the blastemas and the blue square shows
the area displayed in the fluorescent panels. Control animals show
an anterior blastema with a couple of eyes, where the pigmentary
cup can be seen in the live images (black arrows) and the
photosentitive cells and optic chiasm in anti-VC1 staining (white
arrows and green arrow, respectively). Smed-smg-1(RNAi) animals
show varying sizes of blastemas with a low degree of eye
differentiation displayed in the live images (black arrows). The
anti-VC1 staining shows the presence of underdeveloped photo-
sensitive cells (white arrows) and no optic chiasma. Panels show
maximum projections of the dorsal-most confocal sections, the
medial-most confocal sections and the ventral-most confocal
sections of anterior regeneration in 7 dR trunks. Asterisks indicate
the position of the eyes. Panels show the distribution of neoblasts
(cat-1), neoblast early progeny (cat-2) and neoblast late progeny (cat-
3) markers (n$4). The white arrow indicates the presence of cat 1
and H3P+ cells in the cat-2 and cat-3 compartments in front of the
eyes in Smed-smg-1(RNAi) animals. Lower panels show a very
undeveloped brain as seen by synapsin staining (dorsal-most
maximum confocal projection) similar to the phenotype at 20 dR
(Figure 2 in main manuscript). Scale bars indicate 300 mm.
(PDF)
Figure S4 During regeneration, Smed-smg-1(RNAi) animals with
abnormal blastemas progressed to form outgrowths and die. A.
Panels show some examples of planarians at 30–35 dR presenting
hyperplasia and outgrowths. Green arrows indicate epidermal
hyperplasia and black arrows indicate outgrowths. Scale bars
indicate 300 mm. B. The cartoon represents a sagittal paraffin
section. The orange square shows the area of the section displayed
in the fluorescent panels. Panels are confocal maximum
projections of slices performed on 10 mm paraffin sections. White
arrows indicate the multilayered epidermis in Smed-smg-1(RNAi)
animals (n = 10/10 planarians). Scale bar indicates 50 mm.
(PDF)
Figure S5 Smed-smg-1(RNAi) and Smed-tor(RNAi) animals show
similar number of Smedwi-1+ cells before amputation to control
RNAi animals. Smedwi-1+ cells quantification in 0.035 mm2
equivalent regions of the animals, anterior and posterior to the
pharynx, prior to amputation in Smed-smg-1 and Smed-tor RNAi
animals. Error bars are s.d from the mean. No significant
differences P.0.05 (ns) were observed in relation to control RNAi
animals using two-tailed Student’s test with equal sample variance.
$5 planarians per time point.
(PDF)
Figure S6 Smed-smg-1 RNAi animals show anterior expansion of
cat-1 and cat-3 compartments. Volume in mm3 of cat-1 and cat-2
compartments in Smed-smg-1 RNAi compared to control RNAi
animals quantified from the region of the eyes until the tip of the
head. Error bars are s.d from the mean and three asterisks indicate
P,0.001 using two-tailed Student’s test with equal sample
variance relative to control RNAi animals.
(PDF)
Figure S7 Smed-smg-1(RNAi) animals show a posterior-dorsal
expansion of the neoblast compartment at posterior-facing
blastemas and an accumulation of late neoblast progeny at the
tip of the blastema. The yellow square on the cartoon shows the
area displayed in the fluorescent panels. Panels show maximum
projections of 20 d posterior regenerating trunks. Panels show the
distribution of neoblasts (cat-1), H3P+ cells, and neoblast late
progeny (cat-3) markers (n = 6/6). The blue box indicates the area
of high magnification. Scale bars indicate 300 mm and 50 mm in
the high magnifications.
(PDF)
Figure S8 Smed-smg-1(RNAi) animals display differentiation
problems during regeneration. A. The yellow square on the
cartoon shows the area displayed in the fluorescent panels. Panels
show maximum projections of the dorsal-most and the ventral-
most confocal sections for the most developed brain observed at
20 dR planarians (stained with anti-SYNAPSIN). Control planar-
ians for these images are seen in Figure 2E in main manuscript. B.
The yellow square on the cartoon shows the area displayed in the
fluorescent panels. Panels show maximum projections of 20 days
posterior regenerating trunks. Anti-BCAT-2 shows the epithelia of
the gut. Arrows indicate that the end of the posterior gut branches
display anastomoses in Smed-smg-1(RNAi) animals but are not fused
in controls (n = 6/6 versus n= 0/6 in controls). Double arrows
show that the posterior gut branches are thicker in Smed-smg-
1(RNAi) than controls (n = 6/6). It was not possible to determine
from this experiment if the higher thickness is due to an increase in
cell number or an increase in cell size. Scale bars indicate 300 mm.
(PDF)
Figure S9 Homeostatic Smed-smg-1(RNAi) animals show hyper-
proliferation, mitoses in front of the eyes with late neoblast
progeny rarely observed in outgrowths. A. Representative images
showing H3P staining at 9 days after the last injection. Scale bars
indicate 300 mm. B. The cartoon shows a sagittal paraffin section.
The orange square shows the region represented in the panels.
The arrows indicate Smed-AGAT-1+ cells (n = 1/4 planarians). C.
The cartoon indicates the area showed in the panels. Panels are
confocal projections of anti-phospho-tyrosine immunofluores-
cence, pseudocolored according to the depth of the focal plane:
dorsal-most sections are shown in magenta; deeper sections in
green. Smed-smg-1(RNAi) animals display mitosis (white arrows) in
front of the eyes (red arrows) (n = 3/7). Scale bars indicate
150 mm. Scale bars indicate 50 mm.
(PDF)
Figure S10 Smed-smg-1 restricts the mitotic response to feeding.
A, B. Tables show Smed-smg-1(RNAi) feeding phenotype progres-
sion compared to controls. d are days after the last injection. A.
Homeostasis phenotypes. B. Phenotypes in trunks at 25 d of
regeneration. C. Number of H3P positive cells per mm2 in control
and Smed-smg-1 RNAi planarians 1 d after feeding the corre-
sponding dsRNAs. Error bars are s.d from the mean, the asterisks
indicate P,0.01 using two-tailed Student’s test with equal sample
variance relative to the controls. n$5.
(PDF)
Figure S11 SMED-TOR and SMED-RAPTOR conserved
domains. A. Schematic illustration of the domains present on
SMED-TOR compared to human mTOR. B. Schematic
illustration of the domains present on SMED-RAPTOR com-
pared to human RAPTOR. RNC domain accounts for RAPTOR
N-terminal conserved domain.
(PDF)
Figure S12 Smed-lst8 is a bona fide LST8, is broadly expressed in
the whole planarian body and RNAi experiments show a very
weak phenotype however similar to the ones obtained for Smed-tor
and Smed-raptor. A. Smed-lst8 is broadly expressed in the planarian
body (n= 30/30 in three independent experiments). B. The
cartoon shows the levels of transverse amputation performed in the
experiment (arrows) and highlights the trunk piece (dotted red
circle), which was kept to follow anterior and posterior
regeneration in all the experiments. Panels show 16 dR trunks.
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Dotted red lines define the blastemas. Smed-lst8 RNAi planarians
show a reduced blastema compared to controls. Double Smed-smg-
1/Smed-lst8 RNAi experiments show Smed-lst8 phenotype. C.
Relative expression of Smed-smg-1 and Smed-lst8 at 10 days of
regeneration after single or double RNAi experiments. Expression
levels are relative to gfp RNAi injected animals (dotted line).
Similar levels of downregulation for the different genes are
observed in single or double RNAi experiments (P.0.05). Error
bars are s.d from the mean. Asterisks indicate P,0.001 (three
asterisks) and ns indicates ‘‘not significant’’ using two-tailed
Student’s test with equal sample variance and relative to
expression in control animals. Scale bars indicate 300 mm.
(PDF)
Figure S13 Smed-rictor and Smed-sin1 are bona fide RICTOR and
SIN1, respectively. RNAi experiments of both genes either alone
or combined showed no phenotype. A. E-value of the genes
respect to the human homolog. B. The cartoon shows the levels of
transverse amputation performed in the experiment (arrows) and
highlights the trunk piece (dotted red circle), which was kept to
follow anterior and posterior regeneration in all the experiments.
Panels show 20 dR trunks. Dotted red lines define the blastemas.
Smed-rictor, Smed-sin1 or Smed-rictor/Smed-sin1 RNAi did not show
any phenotype even after three rounds of RNAi and regeneration.
C. Relative expression of Smed-rictor and Smed-sin1 at 10 days of
regeneration after single or double RNAi experiments. Expression
levels are relative to gfp RNAi injected animals (dotted line).
Similar levels of downregulation for the different genes are
observed in single or double RNAi experiments (P.0.05). Error
bars are s.d from the mean. Asterisks indicate P,0.05 (one
asterisk), P,0.01 (two asterisks and P,0.001 (three asterisks) and
ns indicates ‘‘not significant’’ using two-tailed Student’s test with
equal sample variance and relative to expression in control
animals. Scale bars indicate 300 mm.
(PDF)
Table S1 Terminals used for the phylogenetic analysis and their
accession numbers.
(PDF)
Video S1 Cat 1 and cat 3 cells in an anterior 20 d regenerating
control trunk. Only the head is shown. Anterior is to the right.
Smedwi-1+ cells (cat1) are shown in green whereas Smed-AGAT-1+
cells are shown in magenta.
(MOV)
Video S2 Cat 1 and cat 3 cells in an anterior 20 d regenerating
Smed-smg-1(RNAi) trunk. Only the head is shown. Anterior is
defined by the magenta. Smedwi-1+ cells (cat1) are shown in green
whereas Smed-AGAT-1+ cells are shown in magenta. Both cat1 and
cat3 compartments have higher volumes than controls (see Video
S1); cat1 compartment is invading cat 3 compartment, an event
never happening in controls.
(MOV)
Video S3 H3P+ cells are present in the outgrowths. H3P+ cells
are the green dots. The arrows indicate the presence of H3P+ cells
in an outgrowth. Two planarians are displayed in the video.
(MOV)
Video S4 Control RNAi trunks are attracted to food and are
able to eat, at 7 dR.
(AVI)
Video S5 Smed-tor RNAi trunks are attracted to food but are not
able to eat at 7 dR. Please note anterior polarity when moving and
normal movements spite of not having formed a blastema.
(AVI)
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